[vidence for a muscarinic inhibitory mechanism in the cerebral cortex].
D000109:Acetylcholine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D002415:Cats; D002540:Cerebral Cortex / Q000187:drug effects* / Q000502:physiology; D004336:Drug Antagonism; D004558:Electric Stimulation; D004594:Electrophysiology; D005260:Female; D008297:Male; D008464:Mecamylamine / Q000494:pharmacology; D009538:Nicotine / Q000494:pharmacology; D009539:Nicotinic Acids / Q000037:antagonists & inhibitors / Q000494:pharmacology; D010277:Parasympathomimetics / Q000494:pharmacology*; D010830:Physostigmine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D010862:Pilocarpine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D011759:Pyrrolidines / Q000494:pharmacology; D012601:Scopolamine / Q000494:pharmacology; D012640:Seizures / Q000209:etiology; D014203:Tremorine / Q000494:pharmacology
D009539:Nicotinic Acids; D010277:Parasympathomimetics; D011759:Pyrrolidines; D010862:Pilocarpine; D008464:Mecamylamine; D009538:Nicotine; D001285:Atropine; D010830:Physostigmine; D012601:Scopolamine; D000109:Acetylcholine; D014203:Tremorine